HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

5- (bis(3- (2- hydroxyethyl)- 1H- indol- 2- yl)methyl)- 2- hydroxybenzoic acid

a metastasis inhibitor; structure in first source

Also Known As:

BHIMHA compound

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Gan, Taiping: 1 article (01/2016)
2.	Peng, Shiqi: 1 article (01/2016)
3.	Wang, Yuji: 1 article (01/2016)
4.	Wu, Jianhui: 1 article (01/2016)
5.	Yang, Jian: 1 article (01/2016)
6.	Zhao, Ming: 1 article (01/2016)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2016 - "5-(Bis(3-(2-hydroxyethyl)-1H-indol-2-yl)methyl)-2-hydroxybenzoic acid (BHIMHA): showing a strategy of designing drug to block lung metastasis of tumors."
2.	Neoplasm Metastasis (Metastasis) 01/01/2016 - "By analyzing the structures and comparing the docking scores of the known pharmacophores, the authors of this paper designed 5-(bis(3-(2-hydroxyethyl)-1H-indol-2-yl)methyl)-2-hydroxybenzoic acid (BHIMHA) as a promising lead compound to develop metastasis inhibitors. " 01/01/2016 - "5-(Bis(3-(2-hydroxyethyl)-1H-indol-2-yl)methyl)-2-hydroxybenzoic acid (BHIMHA): showing a strategy of designing drug to block lung metastasis of tumors."